Ethiopian Food and Drug Authority Collaborates with Bahrain on Drug Production Control Systems
On March 24, 2024, the Ethiopian Food and Drug Authority (EFDA) engaged in discussions with developers of Bahrain’s electronic drug product control system to explore collaboration opportunities. The meeting involved a presentation by EFDA to the Bahraini developers, focusing on systematic drug monitoring and verification.
During the presentation, EFDA highlighted the development and implementation of electronic systems for drug control, showcasing successes, challenges encountered, and strategies employed to address these challenges within the sector. The Bahraini developers reciprocated by sharing their experiences with the drug production control technology currently utilized in Bahrain.
Heran Gerba, Director General of EFDA, led the discussions and underscored the importance of the electronic drug production control system in enhancing systematic monitoring and verification of drugs. The delegates expressed their commitment to supporting EFDA in modernizing and optimizing drug control efforts.
Furthermore, EFDA requested the Bahraini developers to extend their support to local drug manufacturers and importers in Ethiopia. Two days later, on March 26, 2024, at the commencement of further discussions, Director General Heran emphasized the imperative for local manufacturers and importers to implement drug tracking and traceability systems to ensure the quality, safety, and efficacy of drugs. He stressed the adoption of new technologies and the integration of international knowledge and experience across borders.
EFDA also briefed local stakeholders on the systematic monitoring and verification of drugs, elaborating on technology advancements, achievements, challenges, and mitigation strategies. The constructive dialogue between EFDA officials, local drug manufacturers, and the Drug Manufacturers’ Association focused on identifying collaborative opportunities in digital technology for enhanced control measures.
